Vertice Pharma names new director and promotes Scott Meyers to chief executive officer
30 September 2020 -

Vertice Pharma, a specialty pharmaceuticals company, has named Don DeGolyer as its new director and promoted Scott Meyers to chief executive officer, it was reported on Tuesday.

DeGolyer founded Vertice Pharma in 2015 with a focus to acquire specialty pharmaceutical companies and products, including both branded and generic products.

Meyers has been serving as chief operating officer for Vertice Pharma. He has more than 20 years of pharmaceutical experience with most recent position being vice president & general manager of Fougera Inc. He has also served as a consultant for McKinsey & Company's pharmaceutical practice and as a chemical engineer for Merck & Co.